Fiaccadori Enrico, Maggiore Umberto, Di Motta Tommaso, Morabito Santo, Castellano Giuseppe, Gesualdo Loreto, Cabassi Aderville, Regolisti Giuseppe
G Ital Nefrol. 2013 May-Jun;30(3).
The term 'kidney dysfunction' is increasingly used in cardiological literature to indicate different forms of impaired kidney function which can usually be grouped within the broad categories of Acute Kidney Injury (AKI) or Chronic Kidney Disease (CKD).
In this review, renal function parameters commonly utilized in patients with acutely decompensated heart failure are illustrated. Some concepts of definition and classification of renal dysfunction in this clinical setting are presented, on the basis of the most recent data in the literature. Aspects of epidemiology and limits of methodologies are explored, in addition to the correct interpretation of findings, and the impact and prognostic value of renal dysfunction within the context of heart failure will be discussed.
An impairment of kidney function is frequently observed in patients with heart failure, especially during the acutely decompensated phase (Acutely Decompensated Heart Failure or ADHF). Importantly, this complication may impact negatively on clinical outcomes, as well as directly affecting the choice of therapeutic approach, especially when congestive cardiac failure is present. New, recently proposed bio-markers are indicative of kidney injury and cannot be used to replace classical functional indexes.
The evaluation of kidney function, together with the correct interpretation of the significance of clinical findings and the limitations of specific laboratory results, bears major methodological relevance for the care of patients with heart failure. At the present time, more extensive utilization of the new kidney injury bio-markers cannot be recommended in the care of patients with acute decompensated heart failure.
“肾功能不全”一词在心脏病学文献中越来越多地用于表示不同形式的肾功能损害,这些损害通常可归类为急性肾损伤(AKI)或慢性肾脏病(CKD)这两大类。
在本综述中,阐述了急性失代偿性心力衰竭患者常用的肾功能参数。基于文献中的最新数据,介绍了该临床背景下肾功能不全的一些定义和分类概念。除了对研究结果的正确解读外,还探讨了流行病学方面和方法学的局限性,并将讨论肾功能不全在心力衰竭背景下的影响和预后价值。
心力衰竭患者中经常观察到肾功能损害,尤其是在急性失代偿期(急性失代偿性心力衰竭或ADHF)。重要的是,这种并发症可能对临床结局产生负面影响,并直接影响治疗方法的选择,尤其是在存在充血性心力衰竭时。新提出的生物标志物可指示肾损伤,但不能用于替代经典的功能指标。
对肾功能的评估,以及对临床发现意义和特定实验室结果局限性的正确解读,对心力衰竭患者的护理具有重要的方法学意义。目前,在急性失代偿性心力衰竭患者的护理中,不建议更广泛地使用新的肾损伤生物标志物。